Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era

Published:2016-08-24 Issue:2 Volume:17 Page:519-527
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Bowring M. G.¹,Kucirka L. M.¹²,Massie A. B.¹²,Luo X.¹,Cameron A.¹,Sulkowski M.³,Rakestraw K.¹,Gurakar A.³,Kuo I.⁴,Segev D. L.¹²⁵,Durand C. M.¹³

Affiliation:

1. Department of Surgery; Johns Hopkins University School of Medicine; Baltimore MD

2. Department of Epidemiology; Johns Hopkins School of Public Health; Baltimore MD

3. Department of Medicine; Johns Hopkins University School of Medicine; Baltimore MD

4. Department of Epidemiology and Biostatistics; George Washington University School of Public Health; Washington DC

5. Scientific Registry of Transplant Recipients; Minneapolis MN

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.13976/fullpdf

Reference31 articles.

1. Treatment of hepatitis C after liver transplantation;Berenguer;Clin Liver Dis,2005

2. What determines the natural history of recurrent hepatitis C after liver transplantation?;Berenguer;J Hepatol,2005

3. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation;Berenguer;Am J Transplant,2008

4. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin;Berenguer;J Hepatol,2008

5. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation;Pungpapong;Liver Transpl,2013

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Liver Transplantation From Hepatitis C Virus–positive DCD Donors and Its Utilization Among Centers in the United States;Transplantation;2024-08-22

2. The Spread Pattern of New Practice in Liver Transplantation in the United States;Clinical Transplantation;2024-07

3. Implications of drug intoxication on donor utilization and outcomes in liver transplantation;Clinical Transplantation;2024-03

4. Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission;Transplantation;2024-02-16

5. Donor Viral Hepatitis and Liver Transplantation;Surgical Clinics of North America;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3